What's next for Ebos after the end of that Chemist Warehouse contract

What's next for Ebos after the end of that Chemist Warehouse contract
CEO John Cullity says there isn't double-digit growth to be found in animal or healthcare in Australasia. (Image: Ebos)
Rebecca Stevenson
Ebos chief executive John Cullity says the firm must hunt outside of Australasia for double-digit growth. The dual-listed healthcare and pharmaceutical marketer and wholesaler was looking for growth outside its traditional powerhouse pharmaceutical business, Cullity said. He said Ebos’s pharmacy business in NZ and Australia was solid and stable but had relatively low growth. “Double-digit growth rates are going to be very hard, so we need to broaden the group's base of earnings outside of Australia and New Zealand...

More Markets

NZ sharemarket starts new week up 0.2%
Markets Market Close

NZ sharemarket starts new week up 0.2%

The S&P/NZX 50 Index closed at 13,499.04, up 34.58 points or 0.26%.

Graham Skellern 17 Nov 2025
The Warehouse CEO Mark Stirton unveils cost reset amid margin pressure
Retail

The Warehouse CEO Mark Stirton unveils cost reset amid margin pressure

Continued margin pressure and an unsustainable cost base have led The Warehouse Group to implement a comprehensive cost reset programme, something which could see head office roles slashed to save costs.Chief executive Mark Stirton said the group’s shareholders expect decisive ac...

Staff reporters 17 Nov 2025
Banks accelerate crackdown on ‘mule’ scammers
Finance

Banks accelerate crackdown on ‘mule’ scammers

New technology picks up crooked “muleteers” more quickly.

Andy Macdonald 17 Nov 2025